Role of gender in the toxicity of norcocaine

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 6, 1999, Pages 590-596

  Whittington, Robert A ^a   Iso, Ayako ^a   Khan, Khalida ^a   Cooper, Thomas B ^a   Morishima, Hisayo O ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033152011     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90189-0     Document Type: Article

References (21)

1. 1. Hawks RL, Kopin IJ, Colburn RW, Thoa NB. Norcocaine: a pharmacologically active metabolite of cocaine found in brain. Life Sci 1974;15:2189-95.
2. 2. Stewart DJ, Inaba T, Tang BK, Kalow W. Hydrolysis of cocaine in human plasma by cholinesterase. Life Sci 1977;20:1557-64.
3. 3. Inaba T, Stewart DJ, Kalow W. Metabolism of cocaine in man. Clin Pharmacol Ther 1978;23:547-52.
4. 4. Kloss MW, Rosen GM, Rauckman EJ. N-demethylation of cocaine to norcocaine. Evidence for participation by cytochrome P-450 and FAD-containing monooxygenase. Mol Pharmacol 1983;23:482-5.
5. 5. Misra AL, Pontani RB, Vadlamani NL. Metabolism of norcocaine, N-hydroxy norcocaine and cocaine-N-oxide in the rat. Xenobiotica 1979;9:189-99.
6. 6. Morse AC, Erwin VG, Jones BC. Pharmacogenetics of cocaine: a critical review. Pharmacogenetics 1995;5:183-92.
7. 7. Just WW, Hoyer J. The local anesthetic potency of norcocaine, a metabolite of cocaine. Experientia 1977;33:70-1.
8. 3H-pseudococaine: effect of N-demethylation and c2-epimerization of cocaine on its pharmaeokinetics in the rat. Experentia 1976;32:895-7.
9. 9. Kloss MW, Rosen GM, Rauckman EJ. Cocaine-mediated hepatotoxicity. A critical review. Biochem Pharmacol 1984;33:169-73.
10. 10. Morishima HO, Abe Y, Matsuo M, Akiba K, Masaoka T, Cooper TB. Gender-related differences in cocaine toxicity in the rat. J Lab Clin Med 1993;122:157-63.
11. 11. van Luijtelaar EL, Dirksen R, Vree TB, van Haaren F. Effects of acute and chronic cocaine administration on EEG and behaviour in intact and castrated male and intact and ovariectomized female rats. Brain Res Bull 1996,40:43-50.
12. 12. Lukas SE, Sholar M, Lundahl LH, Lamas X, Kouri E, Wines JD, et al. Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology 1996;125:346-54.
13. 13. Evans MA. Role of protein binding in cocaine-induced hepatic necrosis. J Pharmacol Exp Ther 1983;224:73-9.
14. 14. Harris RZ, Benet LZ, Schwartz JB. Gender effects in pharmacokinetics and pharmacodynamics. Drugs 1995;50:222-39.
15. 15. Boelsterli U, Lanzotti A, Goldlin C, Oertle M. Identification of cytochrome P-450IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes. Drug Metab Dispos 1992;20:96-101.
16. 16. Illsley NP, Lamartiniere CA. Endocrine regulation of rat serum cholinesterase activity. Endocrinology 1981;108:1737-43.
17. 17. Blitt CD, Petty WC, Alberternst EE, Wright BJ. Correlation of plasma cholinesterase activity and duration of action of sucinylcholine during pregnancy. Anesth Analg 1977;56:78-83.
18. 18. Schnider SM. Serum cholinesterase activity during pregnancy, labor and the puerperium. Anesthesiology 1965;26:335-9.
19. 19. Farre M, De La Torre R, Llorente M, Lamas X, Ugena B, Segura J, et al. Alcohol and cocaine interactions in humans. J Pharmacol Exp Ther 1993;266:1364-73.
20. 20. Mets B, Virag L. Lethal toxicity from equimolar infusions of cocaine and cocaine metabolites in conscious and anesthetized rats. Anesth Analg 1995;81:1033-8.
21. 21. Edwards DJ, Bowles SK. Protein binding of cocaine in human serum, Pharmacol Res 1988;5:440-2.